Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prempro Low(er) Clears FDA: .3 mg/1.5 mg Is Start Dose For Osteoporosis

Executive Summary

Wyeth's Prempro osteoporosis prevention treatment should begin with .3 mg conjugated estrogens/1.5 mg medroxyprogesterone following FDA approval of the lowest dose of the hormone therapy June 4

You may also be interested in...



Wyeth Prempro DTC

Wyeth expects to have DTC advertisements within the next several months to promote a lower dose of its hormone replacement therapy Prempro (.45 mg conjugated estrogens/1.5 mg medroxyprogesterone), which was launched July 1 after gaining FDA approval March 12 (1"The Pink Sheet" March 17, 2003, p. 4). Prempro .45 mg/1.5 mg is the middle dosing option in the Prempro franchise following the approval of the Prempro .3 mg/1.5 mg dose June 4 (2"The Pink Sheet" June 16, 2003, p. 35)...

Wyeth Prempro DTC

Wyeth expects to have DTC advertisements within the next several months to promote a lower dose of its hormone replacement therapy Prempro (.45 mg conjugated estrogens/1.5 mg medroxyprogesterone), which was launched July 1 after gaining FDA approval March 12 (1"The Pink Sheet" March 17, 2003, p. 4). Prempro .45 mg/1.5 mg is the middle dosing option in the Prempro franchise following the approval of the Prempro .3 mg/1.5 mg dose June 4 (2"The Pink Sheet" June 16, 2003, p. 35)...

Wyeth Prempro Gets Dementia Warning; FDA Considering HRT Class Labeling

FDA is considering hormone replacement therapy class labeling that would incorporate data from a WHI sub-study showing twice the rate of dementia in patients taking Wyeth's Prempro estrogen/progestin combo

Related Content

UsernamePublicRestriction

Register

PS041977

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel